Position in AMRN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,481,404
+$2,971,990 QoQ
Shares Held
240,761
+559.8% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AMRN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in AMRN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,481,404 | 240,761 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $509,414 | 36,491 | Shares | Defined | 2026-02-17 | |
| 2021-12-31 | $153,891 | 45,665 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $8,156,436 | 1,862,200 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,364,680 | 1,508,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,558,937 | 523,300 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,454,259 | 1,058,019 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $7,671,823 | 1,108,645 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $36,867,960 | 9,216,990 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||